心力衰竭的药物和器械治疗-.ppt

  1. 1、本文档共80页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
心力衰竭的药物和器械治疗-

心力衰竭的药物 和器械治疗 名词解释 CRT: 心脏再同步化治疗 ICD: 埋藏式心脏转复除颤器 CRTD: CRT+ICD SCD-HeFT Sudden Cardiac Death In Heart Failure Trial 1996-2003 2521病人 比较胺碘酮和ICD对严重心衰患者生存情况的影响 心功能II-III EF0.35 无持续室性心动过速病史 SCD-HeFT结论 在II-III级心衰,EF .35,安慰剂组年中死亡率为7.2% ICD治疗降低死亡率23% 胺碘酮治疗不改善死亡率 * Angiotensin converting enzyme inhibitors are the best studied class of agents in HF, with multiple mechanisms of benefit for both HF, coronary disease, and other atherosclerotic vascular disease, as well as diabetic nephropathy. for initiation rather than maintenance of therapy. Which approach should be followed? In the controlled clinical trials of ACEIs, low or intermediate doses were commonly prescribed if higher doses could not be tolerated. In controlled trials with newer agents for HF, intermediate doses rather than high doses of ACEIs were generally used as background therapy. Higher doses of an ACEI were better than low doses in reducing the risk of hospitalization, but they showed similar effects on symptoms and mortality. Clinicians should attempt to use doses that have been shown to reduce the risk of cardiovascular events in clinical trials. If these target doses of an ACEI cannot be used or are poorly tolerated, intermediate doses should be used with the expectation that there are likely to be only small differences in efficacy between low and high doses. More importantly, clinicians should not delay the institution of beta-blockers in patients because of a failure to reach target ACEI doses. Once the drug has been titrated to the appropriate dose, patients can generally be maintained on long-term therapy with an ACEI with little difficulty. Although symptoms may improve in some patients within the first 48 hours of therapy with an ACEI, the clinical responses to these drugs are generally delayed and may require several weeks, months, or more to become apparent. Even if symptoms do not improve, long-term treatment with an ACEI should be maintained to reduce the risk of death or hos

文档评论(0)

skvdnd51 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档